View in EDS HTML Full Text PDF Full Text

Real-world cardiovascular effectiveness of sustained glucagon-like peptide 1 GLP-1 receptor agonist usage in type 2 diabetes.

Saved in:
Bibliographic Details
Title: Real-world cardiovascular effectiveness of sustained glucagon-like peptide 1 GLP-1 receptor agonist usage in type 2 diabetes.
Authors: Sørensen, Kathrine Kold1 (AUTHOR) kathrine.kold.soerensen@regionh.dk, Yazdanfard, Puriya Daniel Würtz1 (AUTHOR), Zareini, Bochra1 (AUTHOR), Pedersen-Bjergaard, Ulrik2,3 (AUTHOR), Kosjerina, Vanja4 (AUTHOR), Andersen, Mikkel Porsborg1,5 (AUTHOR), Munch, Anders6 (AUTHOR), Ohlendorff, Johan Sebastian6 (AUTHOR), Schmid, Stefanie7,8 (AUTHOR), Lanzinger, Stefanie7,8 (AUTHOR), Choudhary, Pratik9 (AUTHOR), Gillies, Clare9 (AUTHOR), Gharibzadeh, Safoora9 (AUTHOR), Lind, Marcus10,11,12 (AUTHOR), Tasselius, Viktor10 (AUTHOR), Michelsen, Jens10 (AUTHOR), Gerds, Thomas Alexander6 (AUTHOR), Torp-Pedersen, Christian1,6 (AUTHOR)
Source: Cardiovascular Diabetology. 10/6/2025, Vol. 24 Issue 1, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14752840
DOI:10.1186/s12933-025-02915-1